Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide

被引:55
作者
Corvaia, N
Tournier, P
Nguyen, TN
Haeuw, JF
Power, UF
Binz, H
Andreoni, C
机构
[1] Centre d'Immunologie Pierre Fabre, Saint-Julien en Genevois
[2] Centre d'Immunologie Pierre Fabre, 74164 St. Julien en Genevois
关键词
D O I
10.1086/514075
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The polypeptide of aa 130-230 of the G protein (G2Na) of respiratory syncytial virus (RSV) was fused to BB, the albumin-binding region of streptococcal G protein, producing BBG2Na, which induced protective immune responses in rodent models. Evaluation of the immune response in mice immunized with BBG2Na in the adjuvant alhydrogel revealed high amounts of interleukin (IL)-5 and some IL-4 in splenocytes restimulated in vitro. This is compatible with a Th2 response. The activation of the Th2 pathway in such mice was further supported by the detection of IL-5 and GaNa-specific IgE in vivo. Of interest, in contrast to immunization with formalin-inactivated RSV, immunization of mice with BBG2Na followed by intranasal RSV challenge did not lead to increased production of IL-5- or G2Na-specific IgE. However, IgG1- and IgG2a-specific antibodies were boosted. These results demonstrate that the Th2 pathway is not enhanced by RSV challenge in BBG2Na-immunized mice.
引用
收藏
页码:560 / 569
页数:10
相关论文
共 40 条
  • [21] Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534
  • [22] The expanding universe of T-cell subsets: Th1, Th2 and more
    Mosmann, TR
    Sad, S
    [J]. IMMUNOLOGY TODAY, 1996, 17 (03): : 138 - 146
  • [23] MOSMANN TR, 1986, J IMMUNOL, V136, P2348
  • [24] HYDROPHOBICITY ENGINEERING TO INCREASE SOLUBILITY AND STABILITY OF A RECOMBINANT PROTEIN FROM RESPIRATORY SYNCYTIAL VIRUS
    MURBY, M
    SAMUELSSON, E
    NGUYEN, TN
    MIGNARD, L
    POWER, U
    BINZ, H
    UHLEN, M
    STAHL, S
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (01): : 38 - 44
  • [25] AN UPDATE ON APPROACHES TO THE DEVELOPMENT OF RESPIRATORY SYNCYTIAL VIRUS (RSV) AND PARAINFLUENZA VIRUS TYPE-3 (PIV3) VACCINES
    MURPHY, BR
    HALL, SL
    KULKARNI, AB
    CROWE, JE
    COLLINS, PL
    CONNORS, M
    KARRON, RA
    CHANOCK, RM
    [J]. VIRUS RESEARCH, 1994, 32 (01) : 13 - 36
  • [26] Nguyen TN, 1994, ADV BIOMAGNETIC SEPA, P73
  • [27] RESPIRATORY SYNCYTIAL VIRUS-INDUCED CYTOKINE PRODUCTION BY A HUMAN BRONCHIAL EPITHELIAL-CELL LINE
    NOAH, TL
    BECKER, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05): : L472 - L478
  • [28] NYREN PA, 1991, VACCINES, V91, P363
  • [29] PULMONARY EOSINOPHILIC RESPONSE TO RESPIRATORY SYNCYTIAL VIRUS-INFECTION IN MICE SENSITIZED TO THE MAJOR SURFACE GLYCOPROTEIN-G
    OPENSHAW, PJM
    CLARKE, SL
    RECORD, FM
    [J]. INTERNATIONAL IMMUNOLOGY, 1992, 4 (04) : 493 - 500
  • [30] HELPER T-CELL RECOGNITION OF RESPIRATORY SYNCYTIAL VIRUS IN MICE
    OPENSHAW, PJM
    PEMBERTON, RM
    BALL, LA
    WERTZ, GW
    ASKONAS, BA
    [J]. JOURNAL OF GENERAL VIROLOGY, 1988, 69 : 305 - 312